YKL-40 is elevated in patients with peripheral arterial disease and diabetes or pre-diabetes
Atherosclerosis, 06/14/2012Batinic K et al.
Authros are first to show that YKL–40 is higher in subjects with peripheral arterial disease. YKL–40 was higher in PAD patients with pre–/diabetes. In addition, YKL–40 was associated with the severity of generalized atherosclerosis estimated by affected vascular beds. All these findings point towards a role of YKL–40 in the progression/prognosis of patients with PAD and concomitant diabetes.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.